Table 3.
Plasma oxalate (μmol/L) | ||||
---|---|---|---|---|
OC3 | Placebo | |||
Absolute values | % change to baseline | Absolute values | % change to baseline | |
Baselinea | ||||
n | 21 | – | 13 | – |
Mean (SD) | 13.92 (7.578) | – | 9.68 (4.024) | – |
Median | 11.00 | – | 8.90 | – |
Min, Max | 7.3, 35.0 | – | 4.5, 18.5 | – |
Week 24a | ||||
n | 21 | 21 | 13 | 13 |
Mean (SD) | 12.38 (7.79) | −12.20 (22.55) | 9.82 (6.877) | 5.23 (68.53) |
Median | 9.00 | −14.42 | 6.70 | −8.45 |
Min, Max | 3.3, 35.0 | −64.5, 30.3 | 3.0, 24.1 | −60.3, 192.3 |
Mean treatment difference | – | −17.43 | – | – |
95% confidence interval | – | −50.21, 15.34 | – | – |
p valueb | – | 0.75 | – | – |
SD standard deviation
a Numbers were derived from a post hoc analysis after the finalisation of the Clinical Study Report (CSR)
b p value was derived after a Wilcoxon-Mann–Whitney-test